Eugit Therapeutics
YC S22Enabling Tissue Targeting of Therapies
San Francisco, CA, USA; South San Francisco, CA, USAFounded 20222 employeeswww.eugittx.com
Team
2
Founded
2022
About
Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years. Cofounded by George Church (Harvard) and funded by Y Combinator (S22).
Tags
Cell Therapy Synthetic Biology Therapeutics Oncology Biotechnology Healthcare
No open roles at this time.
Similar Healthcare startups
Delfino AI
Generative AI for administrative automation in healthcare
Generative AIMachine LearningHealth Tech
Open Jobs —
Team 2
Founded 2022
Dr. Treat
“One Medical for pets.”
TelehealthConsumerDigital Health
Open Jobs —
Team 21
Founded 2022
Entvin
Entvin — Healthcare
SaaSHealth TechB2B
Open Jobs —
Team 5
Founded 2022
InVision Medical Technology
AI Diagnosis of Heart Disease
Artificial IntelligenceHealth TechDiagnostics
Open Jobs —
Team 2
Founded 2022